Insulet lowered its full-year sales outlook, citing weaker U.S. Omnipod demand and lower retention among type 2 diabetes users. The news heightens scrutiny on peers in the insulin pump and CGM space.
Dexcom gains Elliott stake; will add board members and restructure, betting on CGM growth; shares rose 6%.
Morgan Stanley updates ratings for Inspire Medical, DexCom, and Bausch + Lomb, highlighting slowing growth, improving operations, and strong long-term pipelines.
GoodRx and Kroger launched RxSmartSaver at 2,200 pharmacies. Scan a code for instant discounts on brand drugs like Ozempic and Lantus.
